FitLife Brands Pre-Tax Profit Margin 2010-2025 | FTLF
FitLife Brands pre-tax profit margin from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| FitLife Brands Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $0.06B | $0.01B | 18.75% |
| 2024-12-31 | $0.07B | $0.01B | 18.46% |
| 2024-09-30 | $0.06B | $0.01B | 17.46% |
| 2024-06-30 | $0.06B | $0.01B | 16.39% |
| 2024-03-31 | $0.06B | $0.01B | 16.95% |
| 2023-12-31 | $0.05B | $0.01B | 15.09% |
| 2023-09-30 | $0.05B | $0.01B | 15.56% |
| 2023-06-30 | $0.04B | $0.01B | 17.95% |
| 2023-03-31 | $0.03B | $0.01B | 18.75% |
| 2022-12-31 | $0.03B | $0.01B | 25.00% |
| 2022-09-30 | $0.03B | $0.01B | 26.67% |
| 2022-06-30 | $0.03B | $0.01B | 24.14% |
| 2022-03-31 | $0.03B | $0.01B | 24.14% |
| 2021-12-31 | $0.03B | $0.01B | 25.00% |
| 2021-09-30 | $0.03B | $0.01B | 22.22% |
| 2021-06-30 | $0.03B | $0.01B | 25.93% |
| 2021-03-31 | $0.02B | $0.01B | 22.73% |
| 2020-12-31 | $0.02B | $0.00B | 18.18% |
| 2020-09-30 | $0.02B | $0.00B | 15.79% |
| 2020-06-30 | $0.02B | $0.00B | 11.76% |
| 2020-03-31 | $0.02B | $0.00B | 15.79% |
| 2019-12-31 | $0.02B | $0.00B | 15.79% |
| 2019-09-30 | $0.02B | $0.00B | 15.00% |
| 2019-06-30 | $0.02B | $0.00B | 10.00% |
| 2019-03-31 | $0.02B | $0.00B | 5.26% |
| 2018-12-31 | $0.02B | 0 | 0.00% |
| 2018-09-30 | $0.02B | $-0.01B | -47.06% |
| 2018-06-30 | $0.02B | $-0.01B | -56.25% |
| 2018-03-31 | $0.02B | $-0.01B | -58.82% |
| 2017-12-31 | $0.02B | $-0.01B | -55.56% |
| 2017-09-30 | $0.02B | $0.00B | -16.67% |
| 2017-06-30 | $0.02B | $0.00B | -10.53% |
| 2017-03-31 | $0.02B | 0 | 0.00% |
| 2016-12-31 | $0.03B | $0.00B | 4.00% |
| 2016-09-30 | $0.03B | 0 | 0.00% |
| 2016-06-30 | $0.03B | 0 | 0.00% |
| 2016-03-31 | $0.02B | $0.00B | -4.55% |
| 2015-12-31 | $0.02B | $0.00B | -11.11% |
| 2015-09-30 | $0.02B | $0.00B | -5.88% |
| 2015-06-30 | $0.02B | 0 | 0.00% |
| 2015-03-31 | $0.02B | $0.00B | 5.88% |
| 2014-12-31 | $0.02B | $0.00B | 10.53% |
| 2014-09-30 | $0.02B | $0.00B | 14.29% |
| 2014-06-30 | $0.02B | $0.00B | 14.29% |
| 2014-03-31 | $0.02B | $0.00B | 15.00% |
| 2013-12-31 | $0.02B | $0.00B | 15.00% |
| 2013-09-30 | $0.02B | $0.00B | 15.79% |
| 2013-06-30 | $0.02B | $0.00B | 10.53% |
| 2013-03-31 | $0.02B | $0.00B | 10.53% |
| 2012-12-31 | $0.02B | $0.00B | 11.11% |
| 2012-09-30 | $0.02B | $0.00B | 11.11% |
| 2012-06-30 | $0.02B | $0.00B | 12.50% |
| 2012-03-31 | $0.01B | $0.00B | 7.14% |
| 2011-12-31 | $0.01B | 0 | 0.00% |
| 2011-09-30 | $0.01B | $0.00B | 18.18% |
| 2011-06-30 | $0.01B | $0.00B | 40.00% |
| 2011-03-31 | $0.01B | $0.01B | 66.67% |
| 2010-12-31 | $0.01B | $0.01B | 100.00% |
| 2010-09-30 | $0.01B | $0.01B | 100.00% |
| 2010-06-30 | $0.01B | $0.01B | 100.00% |
| 2010-03-31 | $0.01B | $0.01B | 100.00% |
| 2009-12-31 | $0.01B | $0.01B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.128B | $0.064B |
| FitLife Brands, Inc. provides nutritional and fitness enhancement products for health-conscious consumers. The Company's product includes Pump Fuel, ACG3, Core Fuel, Embrace Extreme, Lipo Rush, Cardio Cuts, Dr. Detox, Dr. Cholesterol and Dr. Joints. It market and sells product directly to athletic facilities, gyms and independent retailers. Fitlife Brands, Inc., formerly known as Bond Laboratories Inc., is headquartered in Omaha, Nebraska. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.530B | 28.20 |
| Boston Scientific (BSX) | United States | $156.881B | 39.27 |
| Stryker (SYK) | United States | $150.466B | 31.46 |
| EssilorLuxottica (ESLOY) | France | $133.537B | 0.00 |
| Medtronic (MDT) | Ireland | $110.863B | 16.19 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.634B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.673B | 27.69 |
| ResMed (RMD) | United States | $36.905B | 27.72 |
| GE HealthCare Technologies (GEHC) | United States | $33.485B | 15.90 |
| Agilent Technologies (A) | United States | $32.436B | 21.43 |
| Terumo (TRUMY) | Japan | $27.642B | 35.90 |
| Insulet (PODD) | United States | $22.854B | 89.71 |
| Koninklijke Philips (PHG) | Netherlands | $22.587B | 16.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.181B | 12.32 |
| Baxter (BAX) | United States | $16.247B | 12.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.648B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.767B | 23.55 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.402B | 19.67 |
| Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
| Haemonetics (HAE) | United States | $3.532B | 15.39 |
| ICU Medical (ICUI) | United States | $3.480B | 25.66 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| QuidelOrtho (QDEL) | United States | $2.263B | 15.56 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.81 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.435B | 18.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.264B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.182B | 26.59 |
| BioLife Solutions (BLFS) | United States | $1.121B | 0.00 |
| InMode (INMD) | Israel | $1.020B | 9.34 |
| Phibro Animal Health (PAHC) | United States | $0.973B | 12.44 |
| CeriBell (CBLL) | United States | $0.649B | 0.00 |
| Evolus (EOLS) | United States | $0.625B | 0.00 |
| Owens & Minor (OMI) | United States | $0.570B | 4.73 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.535B | 0.00 |
| Valneva SE (VALN) | France | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.498B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.409B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.335B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.321B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.288B | 51.30 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.53 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.40 |
| Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Brainsway (BWAY) | Israel | $0.187B | 49.55 |
| Quanterix (QTRX) | United States | $0.186B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.58 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.080B | 10.32 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.86 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |